(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÃO FARMACÊUTICA COMPREENDENDO AGONISTAS DE MELATONINA PARA O TRATAMENTO DE HIPERPLASIA PROSTÁTICA BENIGNA

IndeferidaInvention PatentPCT · US1996010135

Application data

Number

PI9608912

Type

Invention Patent

Filing

06/12/1996

Publication

03/02/1999

PCT

US1996010135

Progress at the INPI

Under appeal
  1. Filing06/12/96
  2. Publication03/02/99
  3. Examination
  4. Refused04/26/05
  5. Grant
  6. In force

The application was refused by the INPI on 04/26/2005. The invention was never patented.

Talk to a specialist

Latest action published by the INPI: 04/26/2005. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Eli Lilly And Company

US

See this company's full portfolio

Inventors

D. C. (pessoa física)

US

L. S. (pessoa física)

US

W. J. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

000203 · 06/14/1995

Abstract

Patente de Invenção: "AGONISTAS DE MELATONINA PARA O TRATAMENTO DE HIPERPLASIA PROSTÁTICA BENIGNA" . A presente invenção provê um método para o tratamento de hiperplasia prostática benigna usando-se vários agonistas de melatonina.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Indeferimento

#9.2

04/26/2005

RPI 1790

Conhecimento de parecer técnico

#7.1

03/12/2002

RPI 1627

Notificação de entrada na fase nacional - PCT

#1.3

03/02/1999

RPI 1469

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.